Form 4: Oncology Institute CMO Boosts Stake with RSU Vesting

The Oncology Institute's Chief Medical Officer, Yale Podnos, acquired 2,086 shares of common stock through a fully vested RSU award, increasing his direct beneficial ownership.

Summary

• Yale Podnos, Chief Medical Officer of The Oncology Institute, Inc. (TOI), acquired 2,086 shares of common stock.
• The transaction occurred on November 17, 2025, and was an acquisition (A) at a price of $0.00 per share.
• These shares represent Restricted Stock Unit (RSU) awards that were fully vested upon grant, net of withholding tax obligations.
• Following this transaction, Mr. Podnos directly beneficially owns 237,930 shares of common stock.

Sentiment

Score: 6

Explanation: The sentiment is moderately positive as it indicates a routine executive compensation event where an insider's ownership stake increases, which can be seen as a sign of alignment with shareholder interests. There are no negative disclosures.

Positives

• Chief Medical Officer Yale Podnos increased his direct beneficial ownership in The Oncology Institute, Inc. by 2,086 shares.
• The acquisition stems from fully vested Restricted Stock Unit (RSU) awards, indicating successful achievement of prior performance or tenure conditions.
• Increased insider ownership can signal management's confidence in the company's future prospects and align their interests with shareholders.

Negatives

• No explicit negative information was disclosed in this Form 4 filing.

Risks

• This Form 4 filing does not contain information regarding company-specific risks.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

Insider transactions, such as the vesting and acquisition of RSUs by a Chief Medical Officer, are common across all industries, including healthcare. They typically reflect pre-arranged compensation plans and can be viewed as a routine event in executive compensation.

Stakeholder Impact

• Shareholders: Increased alignment of management's interests with shareholders due to higher insider ownership.
• Employees: May signal stability in executive compensation practices.

Key Dates

Keywords

Oncology Institute, TOI, Yale Podnos, Chief Medical Officer, Form 4, Insider Transaction, RSU, Stock Acquisition, Beneficial Ownership, Healthcare